The Health Ministry mentioned on Saturday that greater than 20 lakh vaccine doses towards the coronavirus have been administered throughout the nation the day past, the highest single-day depend so far. As many as 16,39,663 beneficiaries have been vaccinated for the primary dose — healthcare staff (HCWs) and frontline staff (FLWs) — and 4,13,874 such folks obtained the second shot.
“India recorded a significant milestone in its countrywide COVID19 vaccination drive which started on January 16. More than 20 lakh (20,53,537) vaccine doses were given on Day-56 of the vaccination drive (March 12) through 30,561 sessions,” the ministry mentioned in a press release.
This is the highest single-day vaccine administration so far, it mentioned.
A complete of greater than 2.82 crore (2,82,18,457) vaccine doses have been administered by way of 4,86,314 periods, as per the provisional report.
“These include 72,93,575 HCWs (1st dose), 41,94,030 HCWs (2nd dose), 72,35,745 FLWs (1st dose) and 9,48,923 FLWs (2nd dose), 12,54,468 beneficiaries aged more than 45 years with specific co-morbidities (1st dose) and 72,91,716 beneficiaries aged more than 60 years,” it mentioned.
Eight states constituted 74 per cent of the 20.54 lakh doses administered prior to now 24 hours, with Uttar Pradesh topping the checklist with greater than 3.3 lakh vaccine doses.
Ten states account for 69 per cent of the second dose vaccinations in India and Uttar Pradesh alone accounts for 9.71 per cent — 4,99,242 — of the entire second dose vaccinations within the nation, the ministry mentioned.
It added that Maharashtra, Kerala, Punjab, Karnataka, Gujarat, Tamil Nadu, and Madhya Pradesh reported 87.72 per cent of the brand new circumstances within the final 24 hours, with Maharashtra accounting for 63.57 per cent of India’s whole lively circumstances.
Twenty states and Union territories have lower than 1,000 lively circumstances, the ministry mentioned and 18 of states/Union territories haven’t reported any COVID-19 deaths within the final 24 hours.Â
ALSO READ |Â No proof of blood clot danger in any age group, gender, or batch: AstraZeneca
(*20*)Latest India News